RSV Vaccination in Stem Cell Transplant Recipients

We are studying two RSV vaccines to see how well they work in patients who have received stem cell transplants. The goal is to understand their immune response and effectiveness compared to healthy individuals.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Abrysvo
Abrysvo is a vaccine that helps prevent RSV lung infections in older adults and can protect newborns when given during pregnancy.
Arexvy
Arexvy is a vaccine that helps prevent serious lung illness from RSV in older adults.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

3-O-Desacyl-4'-Monophosphoryl Lipid A
3-O-Desacyl-4'-Monophosphoryl Lipid A is a vaccine adjuvant that helps strengthen the body's immune response to vaccines.
Adjuvanted With As01e
An adjuvant mixture used to boost the body's immune response to vaccines.
Glycoprotein F
Glycoprotein F is a viral fusion protein used as an antigen to stimulate immune protection against certain viral infections.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Institut Jules Bordet
Infectious diseases
Negenmanneke, Belgium
Centre hospitalier universitaire de Liege
Hematology
Tilff, Belgium
Sponsor: Centre hospitalier universitaire de Liege
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.